Low-energy skin radiation patches for treating non-melanoma skin cancer
Official title: Activated GaP-32 for the Treatment of Non-Melanoma Skin Cancer
Funded at Oncopatch, INC · NIH-11314378 · Data updated 2026-11-12
A patient-friendly device idea uses a patch to deliver a tiny amount of radiation right at the skin to treat non-melanoma skin cancer in as few visits.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Oncopatch, INC NIH-funded |
| Lab location | 1 site (Centennial, United States) |
| Project start | September 7, 2026 |
| Project end | August 31, 2027 |
| Funding year | 2026 |
| Award (this year) | $305,893 |
| NIH project number | 1R41CA310335-01 |
| Project ID | NIH-11314378 on NIH RePORTER |
Who could benefit from this research
✓Could help
Ideal candidates are adults with non-melanoma skin cancer lesions suitable for surface radiation therapy and who can follow-up for treatment evaluation.
✕Less likely to help
Patients with deeply invasive skin cancers or lesions not appropriate for surface patch therapy may not benefit from this approach.
What this research studies
This project explores a patch-like device that emits low-energy beta radiation from Phosphorus-32 to treat skin cancers on the surface of the skin. The goal is to provide effective treatment with highly localized dosing, potentially reducing the need for multiple clinic visits. Researchers will test GaP-32 patches and study how well they hold and deliver the radiation safely in a controlled setting. The work involves collaboration between OncoPatch, Colorado School of Mines, and University of Colorado, focusing on making the patch reliable and biocompatible for skin treatment.
Why it matters
Potential benefit: If successful, patients with non-melanoma skin cancer could receive effective treatment in fewer sessions with less impact on daily life.
How similar studies have gone: Prior attempts at patch-based or surface-localized radiation have shown promise, but this specific GaP-32 patch approach is novel.
Where this research is happening
-
Oncopatch, INC
Centennial, United States Active
Researchers
- Principal investigator: Sarazin, Fred — Oncopatch, INC
- Study coordinator: Sarazin, Fred
Related research
Other NIH-funded projects on the same topics.
-
CivaDerm: a new four-day skin cancer radiation bandage
A new four‑day radiation bandage for non-melanoma skin cancer aims to treat facial and other areas without multiple clinic visits or big scars.
-
MOSAIC II: MAP Wound Matrix to speed graft readiness after non-melanoma skin cancer surgery
A randomized trial tests a moldable wound scaffold (MAP Wound Matrix) to speed healing and time to graft-ready skin after head and neck cancer surgeries in adults.
-
Safer medicines to prevent basal and squamous (non‑melanoma) skin cancer
Researchers are developing new, non‑toxic oral rexinoid medicines aimed at preventing basal cell and squamous cell skin cancers, especially for people with weakened immune systems like organ transplant recipients.
-
Creating safe drugs to prevent non-melanoma skin cancer
This study is working on new medications to help prevent skin cancer in people with weakened immune systems, like those who have had organ transplants, by creating safer and more effective options that don’t have the usual side effects of current treatments.
-
New ways to prevent non-melanoma skin cancer
This study is looking for new ways to help prevent non-melanoma skin cancers, like basal cell and squamous cell carcinoma, by understanding how these cancers develop and testing new treatments that could lower your risk.
-
Advancing Treatments for Melanoma and Skin Cancer
This program is looking for new and better ways to treat melanoma and other skin cancers, especially when current treatments aren't enough.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.